Tenure Track Faculty Position in Regenerative Medicine and Cell Biology
Tenure Track Faculty Position in Regenerative Medicine and
Medical University of South Carolina, Department of Regenerative Medicine and Cell Biology
A tenure track faculty position at the Assistant or Associate Professor level is available for a researcher who uses cellular and/or molecular-genetic approaches to address fundamental aspects of human disease. Candidates interested in the study of cardiovascular or digestive disease using stem cells are particularly encouraged to apply. Competitive salary, laboratory space and start-up funds are available. Candidates at the Associate Professor level are expected to bring a vigorous research program with significant extramural funding. Current research strengths in the department include tissue engineering, pluripotent stem cell differentiation, cardiovascular development, digestive disease, and molecular biology of cell function. Research is supported by several excellent core facilities specializing in imaging, genetically modified mice and rats, drug discovery, proteomics, genomics, and flow cytometry. A Ph.D. or M.D./Ph.D. degree (or equivalent), plus additional postdoctoral experience are required. Information about the Department can be found at http://cba.musc.edu.
Applicants should provide a research plan and a curriculum vitae including the names of three references through the MUSC employment portal: http://careers.pageuppeople.com/756/cw/en-us/job/499487/univ-assistant-professor-regenerative-medicine. Review of applications will begin on November 1, 2017 and continue until the position is filled.
The Medical University of South Carolina in Charleston was established in 1824 and is one of the oldest continuously operating medical schools in the United States. It is ranked in the upper quartile of all freestanding academic medical schools. The university has approximately 2,200 graduate and professional students that are supported by 2,000 faculty members. Total annual research funding exceeds of $250 million. This includes funding that supports the NCI–designated Hollings Cancer Center as well as a Clinical and Translational Science Award.
MUSC is an Affirmative Action/Equal Opportunity Employer.